Medline Anterior Hip Pack Recall Affects 14,379 Kits With Olympus Biopsy Valves (2026)
Medline Industries, LP recalled 14,379 anterior hip pack kits distributed nationwide after Olympus biopsy valves showed rubber fragment detachment. The defect can release fragments into the patient’s airway, risking a foreign body in the tracheobronchial tree and prolonging procedures. Stop using the kit and follow recall instructions from Medline and your healthcare provider.
Quick Facts at a Glance
Recall Date
February 16, 2026
Hazard Level
HIGH
Brand
Medline
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS
Hazard Information
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medline Industries, LP or your healthcare provider for instructions
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The Medline anterior hip pack kit is a surgical supply used in hip arthroscopy procedures. It contains disposable biopsy valves supplied by Olympus.
Why This Is Dangerous
Rubber fragments detaching from single-use Olympus biopsy valves can become a foreign body in the airway, potentially requiring removal and causing inflammation or hypoxia.
Industry Context
This recall is not presented as part of a broader industry pattern in the provided data.
Real-World Impact
Hospitals and providers must halt use immediately, manage patient safety risk, and coordinate with Medline for refunds or replacements.
Practical Guidance
How to identify if yours is affected
Verify kit contains Olympus biopsy valves
Check for LOT 23LMD300 on packaging
Confirm UDI-DI numbers 10195327377496 (EA) and 40195327377497 (CS)
Where to find product info
Packaging and accompanying recall notices; FDA recall page and Medline instructions
What timeline to expect
Refunds or replacements typically take several weeks after submission of a claim, depending on Medline’s processing schedule
If the manufacturer is unresponsive
Escalate with hospital procurement, document all communications
File a complaint with FDA MedWatch if disputes delay resolution
Consider contacting the CPSC if consumer products misuse is involved
How to prevent similar issues
Verify supplier recalls before procurement
Check UDI-DI codes and lot numbers for all valve components
Prefer suppliers with clear recall handling policies and rapid replacement programs
Maintain an updated recall contact log for each device type
Documentation advice
Keep copies of recall notices, purchase records, correspondence with Medline, and any incident reports.
Product Details
Model numbers/lot codes: UDI-DI 10195327377496 (EA); 40195327377497 (CS); Lot 23LMD300. Distribution: US nationwide. Sold to healthcare facilities. When sold: Unknown. Price: Unknown.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
14,379 kits recalled total
US nationwide distribution
Lot 23LMD300 with UDI-DI 10195327377496 and 40195327377497
Recalled Olympus biopsy valves inside kits
High-hazard recall with potential for serious medical intervention
Stop-use-immediately and follow manufacturer instructions
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.